WeedMD announced today that in accordance with the provisions of its deferred share unit plan the Company has authorized the issuance of an aggregate of 158,026 deferred share units to certain directors of the Company as compensation for their services.

Deborah Sikkema appointed Chief People Officer to lead the Company’s newly-integrated talent, culture and organizational development initiatives

Distinguished business leader and former Deloitte partner Luciano (Lu) Cacioppo appointed as an independent director and chair of Company’s Audit Committee

Pods for PAX® ERA® and ERA PRO™ cannabis vaporizers to be filled and sold by Company using its terpene-rich biomass and co-marketed under Color Cannabis and Starseed brands

WeedMD announced today its participation in the Jefferies Virtual Cannabis Summit on October 7-8, 2020.

Management to host conference call on Thursday, October 1st, 2020 at 10:00 a.m. Eastern Time

Non-dilutive financing to fund continued growth and accelerate sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients

Medical cannabis dried flower, oils, vaporization products and softgel capsules now available to all registered patients under one simplified online sales system

Fully-licensed Strathroy site approved to cultivate, produce, package and sell dried cannabis, cannabis extracts, topicals and edibles to provincial retail and medical markets

Exclusive new strain added to Color Cannabis line up; includes new vaporization and pre-roll product offerings; as well as new nitrogen-infused packaging

Company to present at the LD 500 Virtual Conference and H.C. Wainwright & Co.’s 22nd Annual Global Investment Conference

The Company will host a conference call on Thursday, September 24th, 2020, at 10 a.m. ET

Fire & Flower’s Revity CBD private label brand produced by CX Industries launches in Saskatchewan cannabis retail stores

WeedMD announced today that in accordance with the provisions of its deferred share unit plan the Company has authorized the grant of an aggregate of 356,434 deferred share units to certain directors of the Company as compensation for their services.

Award-winning products to be manufactured by CX Industries in Canada starting Q4 2020, for sale across all WeedMD’s medical and adult-use channels

Dr. Scully was recently reappointed to the Board of Directors, but a personal matter has arisen which has led him to submit his resignation.

Bruce Croxon is a prominent Canadian entrepreneur and venture capitalist and co-founder of Lavalife.

University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation

WeedMD announced today its financial results for the three months ended March 31, 2020.